Ruo-Kai Lin, Chih-Ming Su, Shih-Yun Lin, Le Thi Anh Thu, Phui-Ly Liew, Jian-Yu Chen, . . . Chin-Sheng Hung. (2022). Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. BMC.
Chicago Style (17th ed.) CitationRuo-Kai Lin, et al. Hypermethylation of TMEM240 Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer. BMC, 2022.
MLA (9th ed.) CitationRuo-Kai Lin, et al. Hypermethylation of TMEM240 Predicts Poor Hormone Therapy Response and Disease Progression in Breast Cancer. BMC, 2022.
Warning: These citations may not always be 100% accurate.